Literature DB >> 8985264

The hyperventilation of cirrhosis: progesterone and estradiol effects.

S J Lustik1, A K Chhibber, J W Kolano, I A Hilmi, L C Henson, M C Morris, O Bronsther.   

Abstract

Progesterone and estradiol are metabolized in the liver and are elevated in patients with cirrhosis. Progesterone stimulates ventilation by activating progesterone receptors in the central nervous system; estradiol may facilitate progesterone's actions by increasing progesterone receptors. This study evaluated whether progesterone and estradiol contribute to the respiratory alkalosis common in cirrhotic patients. Arterial blood gases and progesterone and estradiol levels were obtained in 50 patients with cirrhosis. Multiple linear regression revealed a statistically significant correlation between PaCO2 and progesterone and estradiol (r = .54, P < .05). Patients with severe hyperventilation (PaCO2 < or = 30 mm Hg) had statistically higher levels of progesterone and estradiol than did patients with mild hyperventilation (30 < PaCO2 < or = 35) or normal ventilation (PaCO2 > 35) (P < .05). Although the progesterone levels were two orders of magnitude lower than those associated with hyperventilation in pregnant patients, the increased ventilatory effect may be because of the altered blood-brain barrier (BBB) present in cirrhotic patients. Progesterone and estradiol appear to contribute to the hyperventilation in cirrhotic patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8985264     DOI: 10.1002/hep.510250110

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  9 in total

Review 1.  Electrolyte and Acid-Base Disturbances in End-Stage Liver Disease: A Physiopathological Approach.

Authors:  José Víctor Jiménez; Diego Luis Carrillo-Pérez; Rodrigo Rosado-Canto; Ignacio García-Juárez; Aldo Torre; David Kershenobich; Eduardo Carrillo-Maravilla
Journal:  Dig Dis Sci       Date:  2017-05-13       Impact factor: 3.199

2.  Implications of estradiol and progesterone in pulmonary vasodilatation in cirrhotic patients.

Authors:  R Aller; J L Moya; S Avila; J Villa; V Moreira; R Bárcena; D Boxeida; D A de Luis
Journal:  J Endocrinol Invest       Date:  2002-01       Impact factor: 4.256

3.  The effect of liver transplantation on circulating levels of estradiol and progesterone in male patients: parallelism with hepatopulmonary syndrome and systemic hyperdynamic circulation improvement.

Authors:  R Aller; D A de Luis; V Moreira; D Boixeda; J L Moya; C M Fernandez-Rodriguez; A L San Román; S Avila; R Bárcena
Journal:  J Endocrinol Invest       Date:  2001 Jul-Aug       Impact factor: 4.256

Review 4.  The Hepatoprotective and Hepatotoxic Roles of Sex and Sex-Related Hormones.

Authors:  Linlin Xu; Yuan Yuan; Zhaodi Che; Xiaozhi Tan; Bin Wu; Cunchuan Wang; Chengfang Xu; Jia Xiao
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

Review 5.  The neurosteroid system: an emerging therapeutic target for hepatic encephalopathy.

Authors:  Samir Ahboucha; Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

6.  Arterial hypoxaemia in cirrhosis: fact or fiction?

Authors:  S Møller; J Hillingsø; E Christensen; J H Henriksen
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

7.  Clinical Impact of Intrapulmonary Vascular Dilatation in Candidates for Liver Transplant.

Authors:  Hilary M DuBrock; Michael J Krowka; Kimberly A Forde; Karen Krok; Mamta Patel; Tiffany Sharkoski; Michael Sprys; Grace Lin; Jae K Oh; Carl D Mottram; Paul D Scanlon; Michael B Fallon; Steven M Kawut
Journal:  Chest       Date:  2017-10-05       Impact factor: 9.410

8.  Dyspnea and respiratory muscle strength in end-stage liver disease.

Authors:  Georgios Kaltsakas; Efstathios Antoniou; Anastasios F Palamidas; Sofia-Antiopi Gennimata; Panorea Paraskeva; Anastasios Smyrnis; Antonia Koutsoukou; Joseph Milic-Emili; Nickolaos G Koulouris
Journal:  World J Hepatol       Date:  2013-02-27

Review 9.  Hepatic Encephalopathy: From the Pathogenesis to the New Treatments.

Authors:  Juan Cordoba
Journal:  ISRN Hepatol       Date:  2014-06-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.